Gesche Tallen

Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

Gesche Tallen, Richard Ratei, Georg Mann et al. · Journal of Clinical Oncology · 2010 · 310 citations

Mixed-phenotype Acute Leukemia, Immunology, Chemotherapy Intensity +20

Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group

Arend von Stackelberg, Enrico Völzke, Jörn‐Sven Kühl et al. · European Journal of Cancer · 2010 · 96 citations

Hematological Malignancy, Pediatric Hematology, Medicine +8

Novel Pt(II) anticancer agents and their Pd(II) analogues: syntheses, crystal structures, reactions with nucleobases and cytotoxicities

Christian Mock, Ina Puscasu, M.J. Rauterkus et al. · Inorganica Chimica Acta · 2001 · 79 citations

Inorganic Chemistry, Medicinal Chemistry, Medicine +10

The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination

Subhash Thalappilly, Xiaolan Feng, Svitlana Pastyryeva et al. · PLoS ONE · 2011 · 42 citations · Full text

Apoptosis, Cell Death, Molecular Biology +18

No <i>ING1</i> mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma

Gesche Tallen, Ines Kaiser, Sonja Krabbe et al. · International Journal of Cancer · 2004 · 33 citations